SPOTLIGHT -
FDA approves IXINITY for treatment of hemophilia B in patients 12 years and under
IXINITY is now approved to treat all patients with the hemophilia B to help control bleeding episodes, as well as reduce the frequency of them.
Food Insecurity and the Dangers of Infant Formula Dilution
Primary care digital innovations in type 1 diabetes
Sally Humphrey, DNP, APRN, CPNP-PC, discusses current technology to treat youth with diabetes. Humphrey highlights continuous glucose monitoring systems (CGMs) and how they have evolved and improved.
Demystifying Infant Formula
Early-onset IBD linked to greater risk of diseases with possible autoimmune pathogenesis
Psoriatic arthritis and spondyloarthritis occurred earlier in children and adolescents with IBD than in the matched references without IBD.
Antiviral therapeutics for pediatric influenza, COVID-19, herpes
Ashley Gyura, DNP, CPNP-PC, provides updates presented at the 2024 NAPNAP National Conference, highlighting antiviral therapeutics for influenza, COVID-19, and herpes, among others.